Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study

Write a 2- to 3-page paper that addresses the following:

  • Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you were assigned.
  • Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples.
  • Explain how you might improve the patient’s drug therapy plan and explain why you would make these recommended improvements.
  • Case Study

    Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following:

    · glipizide 10 mg po daily

    · HCTZ 25 mg daily

    · atenolol 25 mg po daily

    · hydralazine 25 mg qid

    · simvastatin 80 mg daily

    · verapamil 180 mg CD daily

    · Review the Resources for this module and consider the impact of potential pharmacotherapeutics for cardiovascular disorders introduced in the media piece.

    · Review the case study assigned by your Instructor for this Assignment.

    · Select one the following factors: genetics, gender, ethnicity, age, or behavior factors.

    · Reflect on how the factor you selected might influence the patient’s pharmacokinetic and pharmacodynamic processes.

    · Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient’s recommended drug therapy.

    · Think about how you might improve the patient’s drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient.

    Cas

    e

    S

    tudy

    Patient

    CB

    has

    a

    hist

    ory

    of

    strokes.

    The

    patient

    has

    been

    diagnosed

    with

    type

    2

    diabetes,

    hypertension,

    and

    hyperlipidemia.

    Drugs

    currently

    prescribed

    include

    the

    following:

    ·

    glipizide

    10

    mg

    po

    daily

    ·

    HCTZ

    25

    mg

    daily

    ·

    atenolol

    25

    mg

    po

    daily

    ·

    hydralazine

    25

    mg

    qid

    ·

    simvastatin

    80

    mg

    daily

    ·

    verapamil

    180

    mg

    CD

    daily

    ·

    Review the Resources for this module and consider the impact of potential

    pharmacotherapeutics for cardiovascular disorders introduced in the media

    piece.

    ·

    Review the case study assigned by your Instructor for t

    his Assignment.

    ·

    Select one the following factors: genetics, gender, ethnicity, age, or behavior

    factors.

    ·

    Reflect on how the factor you selected might influence the patient’s

    pharmacokinetic and pharmacodynamic processes.

    ·

    Consider how changes in the pharmacokinetic and pharmacodynamic processes

    might impact the patient’s recommended drug therapy.

    ·

    Think about h

    ow you might improve the patient’s drug therapy plan based on the

    pharmacokinetic and pharmacodynamic changes. Reflect on whether you would

    modify the current drug treatment or provide an alternative treatment option for

    the patient.

    Case Study

    Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension,

    and hyperlipidemia. Drugs currently prescribed include the following:

     glipizide 10 mg po daily

     HCTZ 25 mg daily

     atenolol 25 mg po daily

     hydralazine 25 mg qid

     simvastatin 80 mg daily

     verapamil 180 mg CD daily

     Review the Resources for this module and consider the impact of potential

    pharmacotherapeutics for cardiovascular disorders introduced in the media

    piece.

     Review the case study assigned by your Instructor for this Assignment.

     Select one the following factors: genetics, gender, ethnicity, age, or behavior

    factors.

     Reflect on how the factor you selected might influence the patient’s

    pharmacokinetic and pharmacodynamic processes.

     Consider how changes in the pharmacokinetic and pharmacodynamic processes

    might impact the patient’s recommended drug therapy.

     Think about how you might improve the patient’s drug therapy plan based on the

    pharmacokinetic and pharmacodynamic changes. Reflect on whether you would

    modify the current drug treatment or provide an alternative treatment option for

    the patient.

  • Review the Resources and identify a clinical issue of interest that can form the basis of a clinical inquiry.